For: | Zeng J, Xie MH, Yang J, Chao SW, Xu EL. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients. World J Clin Cases 2020; 8(17): 3763-3773 [PMID: 32953852 DOI: 10.12998/wjcc.v8.i17.3763] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i17/3763.htm |
Number | Citing Articles |
1 |
Manuel Rubio‐Rivas, Carlos G. Forero, José María Mora‐Luján, Abelardo Montero, Francesc Formiga, Narcís A. Homs, Joan Albà‐Albalate, Laura Sánchez, Jordi Rello, Xavier Corbella. Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(11): 884 doi: 10.1002/phar.2627
|
2 |
Jia Zeng, Xiao-Xia Qi, Wan-Wan Cai, Ya-Ping Pan, Yi Xie. Retrospective analysis of influencing factors on the efficacy of mechanical ventilation in severe and critical COVID-19 patients. World Journal of Clinical Cases 2021; 9(31): 9481-9490 doi: 10.12998/wjcc.v9.i31.9481
|
3 |
Jamal Hussen, Mahmoud Kandeel, Maged Gomaa Hemida, Abdullah I. A. Al-Mubarak. Antibody-Based Immunotherapeutic Strategies for COVID-19. Pathogens 2020; 9(11): 917 doi: 10.3390/pathogens9110917
|
4 |
Victor Gravrand, François Mellot, Felix Ackermann, Marie-Christine Ballester, Benjamin Zuber, James T. Kirk, Krupa Navalkar, Thomas D. Yager, Fabien Petit, Tiffany Pascreau, Eric Farfour, Marc Vasse. Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test. Viruses 2023; 15(2): 419 doi: 10.3390/v15020419
|
5 |
Wiktor Schmidt, Katarzyna Pawlak-Buś, Barbara Jóźwiak, Piotr Leszczyński. Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience. Journal of Clinical Medicine 2023; 12(6): 2429 doi: 10.3390/jcm12062429
|